China NMPA Drug Inspection - Gansu Huangfumi Pharmaceutical Co., Ltd. - Arrowroot
China NMPA drug inspection for Gansu Huangfumi Pharmaceutical Co., Ltd. published April 02, 2018. Drug: Arrowroot. The Gansu Provincial Food and Drug Administration, on March 28, 2018, announced the findings from targeted supervision a
One-time purchase from the GKS catalog. Lifetime access in your library. Single documents and full company profiles available. All sales final.
China NMPA drug inspection for Gansu Huangfumi Pharmaceutical Co., Ltd. published April 02, 2018. Drug: Arrowroot. The Gansu Provincial Food and Drug Administration, on March 28, 2018, announced the findings from targeted supervision a
Access our comprehensive regulatory intelligence platform to analyze patterns, track compliance trends, and stay ahead of regulatory changes.
Transform Regulatory Data into Actionable Intelligence
Join leading pharmaceutical and medical device companies who trust GKS for their regulatory compliance needs.
Try KeyPedia Today
Explore our real use cases and discover our features in depth.
Subscribe to our newsletter
Get the latest updates and insights delivered to your inbox